litlas
ログインアカウント作成

Mark C. Gebhardt

1981–2024 年に発表

89
論文数
23,689
被引用数
79
h 指数
88
i10 指数

被引用数

Mark C. Gebhardt の年別被引用数1983 年: 被引用 4 件1984 年: 被引用 1 件1985 年: 被引用 3 件1986 年: 被引用 2 件1987 年: 被引用 5 件1989 年: 被引用 4 件1990 年: 被引用 9 件1991 年: 被引用 40 件1992 年: 被引用 78 件1993 年: 被引用 89 件1994 年: 被引用 77 件1995 年: 被引用 72 件1996 年: 被引用 71 件1997 年: 被引用 54 件1998 年: 被引用 55 件1999 年: 被引用 82 件2000 年: 被引用 82 件2001 年: 被引用 95 件2002 年: 被引用 85 件2003 年: 被引用 91 件2004 年: 被引用 97 件2005 年: 被引用 162 件2006 年: 被引用 151 件2007 年: 被引用 118 件2008 年: 被引用 153 件2009 年: 被引用 170 件2010 年: 被引用 156 件2011 年: 被引用 122 件2012 年: 被引用 126 件2013 年: 被引用 111 件2014 年: 被引用 121 件2015 年: 被引用 111 件2016 年: 被引用 107 件2017 年: 被引用 127 件2018 年: 被引用 84 件2019 年: 被引用 414 件2020 年: 被引用 477 件2021 年: 被引用 391 件2022 年: 被引用 234 件2023 年: 被引用 147 件2024 年: 被引用 291 件2025 年: 被引用 124 件2026 年: 被引用 1 件1988 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,656 件、この内訳の 33%中国: 引用元論文 523 件、この内訳の 10.4%イタリア: 引用元論文 337 件、この内訳の 6.7%イギリス: 引用元論文 298 件、この内訳の 5.9%ドイツ: 引用元論文 250 件、この内訳の 5%フランス: 引用元論文 226 件、この内訳の 4.5%カナダ: 引用元論文 195 件、この内訳の 3.9%オランダ: 引用元論文 170 件、この内訳の 3.4%日本: 引用元論文 137 件、この内訳の 2.7%スイス: 引用元論文 99 件、この内訳の 2%オーストラリア: 引用元論文 86 件、この内訳の 1.7%スペイン: 引用元論文 85 件、この内訳の 1.7%
0%33%その他 19.1%

機関

分野

  • Medicine76.9%
  • Biochemistry, Genetics and Molecular Biology15.5%
  • Engineering3.2%
  • Immunology and Microbiology2.2%
  • Materials Science0.3%
  • Neuroscience0.3%
  • その他1.6%

トピック

  • Sarcoma Diagnosis and Treatment16.3%
  • Bone Tumor Diagnosis and Treatments8.2%
  • Management of metastatic bone disease4%
  • Cancer-related Molecular Pathways2.8%
  • Orthopaedic implants and arthroplasty1.7%
  • Cancer Research and Treatments1.7%
  • その他65.3%

共著者

全論文

検索で開く
  1. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

    著者: Sigbjørn Smeland, Stefan Bielack, Jeremy Whelan, Mark L. Bernstein, Pancras C.W. Hogendoorn, Mark Krailo, Richard Görlick, Katherine A. Janeway, Fiona C. Ingleby, Jakob Anninga, Imre Antal, Carola Arndt, Ken Brown, Trude Butterfaß‐Bahloul, Gabriele Calaminus, Michael Capra, Catharina Dhooge, Mikael Eriksson, Adrienne M. Flanagan, Godehard Friedel, Mark C. Gebhardt, Hans Gelderblom, Robert E. Goldsby, Holcombe E. Grier, R. J. Grimer, Douglas S. Hawkins, Stefanie Hecker‐Nolting, Kirsten Sundby Hall, Michael S. Isakoff, Gordana Jovic, Thomas Kühne, Leo Kager, Thekla von Kalle, Edita Kabíčková, Susanna Lang, Ching C. Lau, Patrick J. Leavey, Stephen L. Lessnick, Leo Mascarenhas, Regine Mayer‐Steinacker, Paul A. Meyers, Raj Nagarajan, R. Lor Randall, Peter Reichardt, Marleen Renard, Catherine Rechnitzer, Cindy L. Schwartz, Sandra J. Strauss, Lisa A. Teot, Beate Timmermann, Matthew R. Sydes, Neyssa Marina - European Journal of Cancer 2019 被引用: 726

  2. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

    著者: Neyssa Marina, Sigbjørn Smeland, Stefan Bielack, Mark L. Bernstein, Gordana Jovic, Mark Krailo, Jane Hook, Carola Arndt, Henk van den Berg, Bernadette Brennan, Bénédicte Brichard, Ken Brown, Trude Butterfaß‐Bahloul, Gabriele Calaminus, Heike E. Daldrup‐Link, Mikael Eriksson, Mark C. Gebhardt, Hans Gelderblom, Joachim Gerß, Robert E. Goldsby, Allen M. Goorin, Richard Görlick, Holcombe E. Grier, Juliet Hale, Kirsten Sundby Hall, Jendrik Hardes, Douglas S. Hawkins, K. Helmke, Pancras C.W. Hogendoorn, Michael S. Isakoff, Katherine A. Janeway, Heribert Jürgens, Leo Kager, Thomas Kühne, Ching C. Lau, Patrick J. Leavey, Stephen L. Lessnick, Leo Mascarenhas, Paul A. Meyers, Hubert Mottl, Michaela Nathrath, Zsuzsanna Pápai, R. Lor Randall, Peter Reichardt, Marleen Renard, Akmal Safwat, Cindy L. Schwartz, Michaël C.G. Stevens, Sandra J. Strauss, Lisa A. Teot, Mathias Werner, Matthew R. Sydes, Jeremy Whelan - The Lancet Oncology 2016 被引用: 541

  3. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

    著者: Stefan Bielack, Sigbjørn Smeland, Jeremy Whelan, Neyssa Marina, Gordana Jovic, Jane Hook, Mark Krailo, Mark C. Gebhardt, Zsuzsanna Pápai, James S. Meyer, Helen Nadel, R. Lor Randall, Claudia Deffenbaugh, Rajaram Nagarajan, Bernadette Brennan, G. Douglas Letson, Lisa A. Teot, Allen M. Goorin, Daniel Baumhoer, Leo Kager, Mathias Werner, Ching C. Lau, Kirsten Sundby Hall, Hans Gelderblom, Paul A. Meyers, Richard Görlick, Rein hard Windhager, K. Helmke, Mikael Eriksson, Peter M. Hoogerbrugge, Paula J. Schomberg, Per‐Ulf Tunn, Thomas Kühne, Heribert Jürgens, Henk van den Berg, Tom Böhling, Susan Picton, Marleen Renard, Peter Reichardt, Joachim Gerß, Trude Butterfaß‐Bahloul, Carol D. Morris, Pancras C.W. Hogendoorn, Beatrice Seddon, Gabriele Calaminus, Maria Michelagnoli, Catharina Dhooge, Matthew R. Sydes, Mark L. Bernstein - Journal of Clinical Oncology 2015 被引用: 421

  4. A System for the Functional Evaluation of Reconstructive Procedures After Surgical Treatment of Tumors of the Musculoskeletal System

    著者: WILLIAM F. ENNEKING, WILLIAM DUNHAM, Mark C. Gebhardt, Martin Malawar, Douglas Pritchard - Clinical Orthopaedics and Related Research 1993 被引用: 2,210

  5. Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

    著者: Paul A. Meyers, Cindy L. Schwartz, Mark Krailo, John H. Healey, Mark L. Bernstein, Donna L. Betcher, William S. Ferguson, Mark C. Gebhardt, Allen M. Goorin, Michael B. Harris, Eugenie S. Kleinerman, Michael P. Link, Helen Nadel, Michael L. Nieder, Gene P. Siegal, Michael A. Weiner, Robert J. Wells, Richard B. Womer, Holcombe E. Grier - Journal of Clinical Oncology 2008 被引用: 748

  6. Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone

    著者: Holcombe E. Grier, Mark Krailo, Nancy J. Tarbell, Michael P. Link, Christopher Fryer, Douglas J. Pritchard, Mark C. Gebhardt, Paul S. Dickman, Elizabeth J. Perlman, Paul A. Meyers, Sarah S. Donaldson, Sheila Moore, Aaron R. Rausen, Teresa J. Vietti, James S Miser - New England Journal of Medicine 2003 被引用: 1,334

  7. Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

    著者: Paul A. Meyers, Cindy L. Schwartz, Mark Krailo, Eugenie S. Kleinerman, Donna L. Betcher, Mark L. Bernstein, Ernest U. Conrad, William S. Ferguson, Mark C. Gebhardt, Allen M. Goorin, Michael B. Harris, John H. Healey, Andrew G. Huvos, Michael P. Link, Joseph F. Montebello, Helen Nadel, Michael L. Nieder, Judith K. Sato, Gene P. Siegal, Michael A. Weiner, Robert J. Wells, Lester E. Wold, Richard B. Womer, Holcombe E. Grier - Journal of Clinical Oncology 2005 被引用: 719

  8. Presurgical Chemotherapy Compared With Immediate Surgery and Adjuvant Chemotherapy for Nonmetastatic Osteosarcoma: Pediatric Oncology Group Study POG-8651

    著者: Allen M. Goorin, Douglas J. Schwartzentruber, Meenakshi Devidas, Mark C. Gebhardt, Alberto G. Ayala, Michael B. Harris, Lee J. Helman, Holcombe E. Grier, Michael P. Link - Journal of Clinical Oncology 2003 被引用: 395

  9. MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32

    著者: Andrew D. Kelly, Benjamin Haibe‐Kains, Katherine A. Janeway, Katherine E. Hill, Eleanor Howe, Jeffrey D. Goldsmith, Kyle C. Kurek, Antonio R. Pérez‐Atayde, Nancy Francoeur, Jian‐Bing Fan, Craig April, Hal E. Schneider, Mark C. Gebhardt, Aedín C. Culhane, John Quackenbush, Dimitrios Spentzos - Genome Medicine 2013 被引用: 118

  10. Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group

    著者: Cindy L. Schwartz, Leonard H. Wexler, Mark Krailo, Lisa A. Teot, Meenakshi Devidas, Laurel J. Steinherz, Allen M. Goorin, Mark C. Gebhardt, John H. Healey, Judith K. Sato, Paul A. Meyers, Holcombe E. Grier, Mark L. Bernstein, Steven E. Lipshultz - Pediatric Blood & Cancer 2015 被引用: 92

  11. USP6 and CDH11 Oncogenes Identify the Neoplastic Cell in Primary Aneurysmal Bone Cysts and Are Absent in So-Called Secondary Aneurysmal Bone Cysts

    著者: André M. Oliveira, Antonio R. Pérez‐Atayde, Carrie Y. Inwards, Fabíola Medeiros, Victoria Derr, Bae‐Li Hsi, Mark C. Gebhardt, Andrew E. Rosenberg, Jonathan A. Fletcher - American Journal Of Pathology 2004 被引用: 432

  12. Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study

    著者: Linda Granowetter, Richard B. Womer, Meenakshi Devidas, Mark Krailo, Chenguang Wang, Mark L. Bernstein, Neyssa Marina, Patrick J. Leavey, Mark C. Gebhardt, John H. Healey, Robert C. Shamberger, Allen M. Goorin, James S Miser, James S. Meyer, Carola A.S. Arndt, Scott L. Sailer, Karen J. Marcus, Elizabeth J. Perlman, Paul S. Dickman, Holcombe E. Grier - Journal of Clinical Oncology 2009 被引用: 332

  13. Clinical and Biochemical Manifestations of Hyaluronidase Deficiency

    著者: Marvin R. Natowicz, M. Priscilla Short, Yu Wang, G. Richard Dickersin, Mark C. Gebhardt, Daniel I. Rosenthal, Katherine B. Sims, Andrew E. Rosenberg - New England Journal of Medicine 1996 被引用: 205

  14. Long-Term Results of Allograft Replacement in the Management of Bone Tumors

    著者: Henry J. Mankin, Mark C. Gebhardt, L. Candace Jennings, Dempsey S. Springfield, William W. Tomford - Clinical Orthopaedics and Related Research 1996 被引用: 671

  15. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi‐modality therapy: A report from the Children's Oncology Group

    著者: Patrick J. Leavey, Leo Mascarenhas, Neyssa Marina, Zhengjia Chen, Mark Krailo, James S Miser, Ken Brown, Nancy J. Tarbell, Mark L. Bernstein, Linda Granowetter, Mark C. Gebhardt, Holcombe E. Grier - Pediatric Blood & Cancer 2008 被引用: 204

  16. Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group

    著者: Steven G. DuBois, Mark Krailo, Mark C. Gebhardt, Sarah S. Donaldson, Karen J. Marcus, John P. Dormans, Robert C. Shamberger, Scott L. Sailer, Richard W. Nicholas, John H. Healey, Nancy J. Tarbell, R. Lor Randall, Meenakshi Devidas, James S. Meyer, Linda Granowetter, Richard B. Womer, Mark L. Bernstein, Neyssa Marina, Holcombe E. Grier - Cancer 2014 被引用: 188

  17. Phase II/III Trial of Etoposide and High-Dose Ifosfamide in Newly Diagnosed Metastatic Osteosarcoma: A Pediatric Oncology Group Trial

    著者: Allen M. Goorin, Michael B. Harris, Mark L. Bernstein, William S. Ferguson, Meenakshi Devidas, Gene P. Siegal, Mark C. Gebhardt, Cindy L. Schwartz, Michael P. Link, Holcombe E. Grier - Journal of Clinical Oncology 2002 被引用: 145

  18. Editorial

    著者: Seth S. Leopold, Lee Beadling, Matthew B. Dobbs, Mark C. Gebhardt, Paul A. Lotke, Paul Manner, Clare M. Rimnac, Montri D. Wongworawat - Clinical Orthopaedics and Related Research 2013 被引用: 99

  19. p53 functions as a cell cycle control protein in osteosarcomas.

    著者: Lisa Diller, J Kassel, C. Nelson, Magdalena A. Gryka, Gregory Litwak, Mark C. Gebhardt, B Bressac, Mehmet Öztürk, Suzanne J. Baker, Bert Vogelstein - Molecular and Cellular Biology 1990 被引用: 767

  20. Aneurysmal Bone Cyst: A Review of 150 Patients

    著者: Henry J. Mankin, Francis J. Hornicek, Eduardo J. Ortiz‐Cruz, Jorge Villafuerte, Mark C. Gebhardt - Journal of Clinical Oncology 2005 被引用: 460

  21. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas

    著者: Thomas F. DeLaney, Ira J. Spiro, Herman D. Suit, Mark C. Gebhardt, Francis J. Hornicek, Henry J. Mankin, Andrew Rosenberg, Daniel I. Rosenthal, Fariba Miryousefi, Marcus Ancukiewicz, David C. Harmon - International Journal of Radiation Oncology*Biology*Physics 2003 被引用: 307

  22. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes

    著者: André M. Oliveira, Antonio R. Pérez‐Atayde, Paola Dal Cin, Mark C. Gebhardt, Chang-Jie Chen, James R. Neff, George D. Demetri, Andrew E. Rosenberg, Julia A. Bridge, Jonathan A. Fletcher - Oncogene 2005 被引用: 248

  23. p53 Functions as a Cell Cycle Control Protein in Osteosarcomas

    著者: Lisa Diller, J Kassel, Camille E. Nelson, Magdalena A. Gryka, Gregory Litwak, Mark C. Gebhardt, Brigitte Bressac–de Paillerets, Mehmet Öztürk, Suzanne J. Baker, Bert Vogelstein, Stephen Friend - Molecular and Cellular Biology 1990 被引用: 228

  24. Vinblastine and Methotrexate for Desmoid Fibromatosis in Children: Results of a Pediatric Oncology Group Phase II Trial

    著者: Stephen X. Skapek, William S. Ferguson, Linda Granowetter, Meenakshi Devidas, Antonio R. Pérez‐Atayde, Louis P. Dehner, Fredric A. Hoffer, Roseanne Speights, Mark C. Gebhardt, Gary V. Dahl, Holcombe E. Grier - Journal of Clinical Oncology 2007 被引用: 195